Clinico-epidemiological profile of chronic kidney disease patients attending a tertiary care hospital in Goa, India
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262624Keywords:
Chronic kidney disease, Chronic kidney disease of unknown origin, Diabetic kidney disease, Epidemiology, IndiaAbstract
Background: Chronic kidney disease (CKD) is a major public health problem associated with substantial morbidity and mortality. While diabetes mellitus and hypertension remain the leading causes of CKD, increasing attention is being directed toward chronic kidney disease of unknown etiology (CKDu). In Goa, particularly the southern taluka of Canacona, systematic hospital-based data on CKD are limited.
Methods: This cross-sectional study was conducted at Goa Medical College between May 2023 and April 2024. Consenting adults (>18 years) with CKD, defined according to KDIGO 2024 criteria, were enrolled. Demographic, socioeconomic, clinical, biochemical, radiological, and etiological data were collected. CKDu was defined as CKD in the absence of diabetes mellitus, long-standing hypertension sufficient to explain kidney disease, or any other identifiable cause after standard evaluation. Statistical analysis was performed using SPSS version 26.
Results: Among 345 patients, 243 (70.4%) were male, with a mean age of 55.0±14.3 years. Hypertension (93.6%) and diabetes mellitus (60.9%) were the most common comorbidities. Anemia was present in 84.6% of patients, and CKD–mineral and bone disorder abnormalities were frequent. Diabetic kidney disease and hypertensive nephropathy were the predominant etiologies. CKDu was identified in 27 patients (7.8%), with marked clustering in Canacona taluka (20 cases).
Conclusions: CKD in Goa is predominantly driven by diabetes and hypertension. However, clustering of CKDu cases in Canacona suggests a potential hotspot warranting focused surveillance and environmental investigations.
References
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kid Int Supplem. 2022;12(1):7-11.
Sharma MG, Popli H. Challenges for lower-middle-income countries in achieving universal healthcare: an Indian perspective. Cureus. 2023;15(1).
Talukdar R, Ajayan R, Gupta S, Biswas S, Parveen M, Sadhukhan D, et al. Chronic kidney disease prevalence in India: a systematic review and meta‐analysis from community‐based representative evidence between 2011 to 2023. Nephrol. 2025;30(1):e14420.
Ying M, Shao X, Qin H, Yin P, Lin Y, Wu J, et al. Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019. Nephron. 2024;148(2):113-23.
Francis A, Harhay MN, Ong AC, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nature Revi Nephrol. 2024;20(7):473-85.
Rao IR, Bangera A, Nagaraju SP, Shenoy SV, Prabhu RA, Rangaswamy D, et al. Chronic kidney disease of unknown aetiology: a comprehensive review of a global public health problem. Trop Medi Int Heal. 2023;28(8):588-600.
Abraham G, Agarwal SK, Gowrishankar S, Vijayan M. Chronic kidney disease of unknown etiology: hotspots in India and other Asian countries. In: Seminars in Nephrology. 2019;39(3):272-7.
Nerli RB, Metgud T, Hiremath MB, Guntaka A, Patil S, Prabha V. Prevalence of renal disorders among the residents of Canacona in India: analysis of the data from a free urological medical camp. Indian J Sci Technol. 2010;3(3):296-8.
Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kid Int. 2024;105(4):684-701.
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. Jama. 2019;322(13):1294-304.
Kumar V, Yadav AK, Sethi J, Ghosh A, Sahay M, Prasad N, et al. The Indian chronic kidney disease (ICKD) study: baseline characteristics. Clin Kid J. 2022;15(1):60-9.
Gani A. Socioeconomic determinants of chronic kidney disease: a comprehensive literature review. Afr J Biomed Res. 2025;28.
Nicholas SB, Kalantar-Zadeh K, Norris KC. Socioeconomic disparities in chronic kidney disease. Advan Chr Kid Dis. 2015;22(1):6-15.
Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kid Int. 2004;66(2):753-60.
Waziri B, Duarte R, Naicker S. Chronic kidney disease–mineral and bone disorder (CKD-MBD): current perspectives. Int J Nephrol Renovasc Dis. 2019:263-76.
Loutradis C, Skodra A, Georgianos P, Tolika P, Alexandrou D, Avdelidou A, et al. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study. W J Nephrol. 2016;5(4):358.
Krolewski AS, Skupien J, Rossing P, Warram JH. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kid Int. 2017;91(6):1300-11.
Wijkström J. Chronic kidney disease of unknown etiology in Central America and Sri Lanka: renal morphology and clinical characteristics. Karolinska Institutet; 2017 Sep 7.
Galhotra A, Rathore V, Pal R, Nayak S, Ramasamy S, Patel S, et al. Clinico-epidemiological profile of patients with chronic kidney diseases of unknown etiology: A hospital-based, cross-sectional study from Central India. Ind J Nephrol. 2023:10-4103.
Ramavajula A, Sahay M, Ismal K, Kavadi A, Enganti R, Gowrishankar S. Chronic kidney disease of unknown etiology in Telangana: is it different? Ind J Nephrol. 2026;36:44-8.
John O, Gummudi B, Jha A, Gopalakrishnan N, Kalra OP, Kaur P, et al. Chronic kidney disease of unknown etiology in India: What do we know and where we need to go. Kid Int Rep. 2021;6(11):2743-51.
Downloads
Published
How to Cite
Issue
Section
